Revance Therapeutics, Inc.
Botulinum toxin and the treatment of primary disorders of mood and affect

Last updated:

Abstract:

A method of treating circadian rhythm disorders includes identifying a subject with a circadian rhythm disorder or at least one symptom of a circadian rhythm disorder and administering an effective amount of a composition comprising a botulinum toxin and a pharmaceutically acceptable carrier to said subject thereby reducing at least one symptom of a circadian rhythm disorder.

Status:
Grant
Type:

Utility

Filling date:

14 Sep 2015

Issue date:

15 Oct 2019